Side Effects of MS Therapies: Natalizumab – Medicine/Therapy – Multiple Sclerosis News
Very high effectiveness and negligible side effects: When natalizumab, trade name Tysabri, was approved once morest relapsing-remitting multiple sclerosis and especially once morest aggressive courses,